The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
出版年份 2019 全文链接
标题
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 69, Issue 3, Pages 343-354
出版商
Springer Science and Business Media LLC
发表日期
2019-12-21
DOI
10.1007/s00262-019-02453-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
- (2019) Arielle Elkrief et al. OncoImmunology
- Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma.
- (2019) Archana Agarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
- (2019) Uqba Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics
- (2019) F Huemer et al. ANNALS OF ONCOLOGY
- Effect of antibiotic exposure in patients with metastatic melanoma treated with PD-1 inhibitor or CTLA-4 inhibitor or a combination of both.
- (2019) Vidit Kapoor et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of an Italian CORE-IMMUNO study: Safety and clinical-related biomarkers as predictors of immunotherapy (IT) benefit in real-world treatment of various advanced tumors (ATs).
- (2019) Cristina Masini et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of medication (Med) and antibiotic (Abx) use with response and survival in advanced melanoma (MEL) receiving PD-1 inhibitors.
- (2019) Amit Hemadri et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of antibiotic use on clinical outcomes in patients with urothelial cancer receiving a programmed death protein 1 or programmed death ligand 1 (anti-PD-1/L1) antibody.
- (2019) Chana Weinstock et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of antibiotics and proton pump inhibitors on clinical outcomes of immune check point blockers in advanced non-small cell lung cancers and metastatic renal cell cancer.
- (2019) Amit Kulkarni et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
- (2019) Sha Zhao et al. LUNG CANCER
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
- (2019) Clara Depommier et al. NATURE MEDICINE
- Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
- (2019) Julia Ouaknine Krief et al. Journal for ImmunoTherapy of Cancer
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
- (2019) Giovanni Rossi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC).
- (2018) Aly-Khan A. Lalani et al. JOURNAL OF CLINICAL ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
- (2018) Florian Huemer et al. Oncotarget
- Impact of anti-infectious and corticosteroids on immunotherapy: Nivolumab and pembrozilumab follow-up in a French study.
- (2018) Jean-Philippe Metges et al. JOURNAL OF CLINICAL ONCOLOGY
- Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
- (2018) Nadina Tinsley et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
- (2018) Jibran Ahmed et al. OncoImmunology
- Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
- (2018) S Sen et al. ANNALS OF ONCOLOGY
- The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match
- (2018) Vivek Subbiah et al. ONCOLOGIST
- Recovery of gut microbiota of healthy adults following antibiotic exposure
- (2018) Albert Palleja et al. Nature Microbiology
- Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
- (2017) Lisa Derosa et al. JOURNAL OF CLINICAL ONCOLOGY
- P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors
- (2017) J. Thompson et al. Journal of Thoracic Oncology
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients
- (2009) Michel J. van Vliet et al. PEDIATRIC BLOOD & CANCER
- The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
- (2008) Les Dethlefsen et al. PLOS BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now